Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma × Imiquimod × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Keratosis, Actinic 28 Uterine Cervical Dysplasia 12 Carcinoma, Basal Cell 12 Melanoma 7 Glioblastoma 6 Glioma 5 Breast Neoplasms 5 Uterine Cervical Neoplasms 4 Condylomata Acuminata 4 Precancerous Conditions 3 Papillomavirus Infections 3 Keratosis 3 Hutchinson's Melanotic Freckle 3 Vulvar Neoplasms 2 Urinary Bladder Neoplasms 2 Squamous Intraepithelial Lesions 2 Non-Muscle Invasive Bladder Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Hemangioma, Capillary 2 HIV Infections 2 Ependymoma 2 Colorectal Neoplasms 2 Brain Neoplasms 2 Astrocytoma 2 Warts 1 Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) 1 Virus Diseases 1 Vaginal Neoplasms 1 Stomach Neoplasms 1

Interventions

Oxaliplatin 42 Gemcitabine 41 Fluorouracil 37 pembrolizumab 29 Capecitabine 29 Leucovorin 26 Docetaxel 25 Cisplatin 24 Paclitaxel 21 Carboplatin 18 Bevacizumab 17 Irinotecan 16 130-nm albumin-bound paclitaxel 16 Radiotherapy 15 Pemetrexed 15 Nivolumab 13 Albumin-Bound Paclitaxel 13 Cyclophosphamide 10 Ramucirumab 9 zolbetuximab 7 Trastuzumab 7 Radiosurgery 7 Drug Therapy 7 trastuzumab deruxtecan 6 cemiplimab 6 Taxes 6 Erlotinib Hydrochloride 6 Blood Specimen Collection 6 durvalumab 5 Sorafenib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02234921 2018-10-11

DRibble

UbiVac

Phase 1 Completed

Adenocarcinoma, Neoplasm Metastasis, Sialorrhea

Data powered by HemOnc (CC BY 4.0) Colophon ⚡